A Team Approach to ADCs in Bladder Cancer – [Video Podcast] Ep. 62 accc-cancer.org/view/a-team-ap… via @ACCCBuzz

Just finished chairing a great session on HER2 in bladder cancer at #BCANTT26. Congrats to Funda Merric-Berstram and Virginia Borges for great talks on the evolution of HER2 therapy in breast cancer, and @IyerGopa for his review of our current knowledge about HER2 therapy.

Excellent session on AI in bladder cancer at #BCAN2026. Great talk by Dr Travis Zack at @openevidence

Great to see our UCSF Bladder Cancer Program highlighted in GU Oncology Now. Great teamwork to advance care for our patients!

guoncologynow.com/post/precision…

#bladdercancer
#precisionmedicine
@UCSF
@UCSFCancer

Awesome #BCANTT24 this year. Great representation from #UCSF!

Long awaited combination of Sacituzumab plus Immunotherapy in the JCO. Congrats to Dr Grivas @PGrivasMDPhD all the authors.

pubmed.ncbi.nlm.nih.gov/38261969/

Great talk today by Kala Sridhar @kalasri3 at #ESMOAsia2023 on the current landscape in bladder cancer. So many new developments in such a short time!

Awesome end to #UromigosLive with my good friend Vadim @koshkin85 . Nashville is gorgeous

Great Rising Stars session at #UromigosLive.

Great start to Uromigos Live meeting. Lots to discuss in frontline mUC space. All star pane here! #UromigosLive 2023

So excited to to finally see our trial of combining check point inhibitors (pembrolizumab) with a single dose of 177Lu-PSMA-617 finally get published in @TheLancetOncol. Great team work @UCSFCancer. Amazing PSA50 (56%) and duration of response with a single dose of RLT!

Concluding another amazing @PCFnews @PCF_Science retreat with lots of great science and celebration of 2023 class of Young Investigators @UCSFCancer @UCSFUrology @HemoncUcsf @xiaolin_zhu @Bajji @AlanBryce9 @PBarataMD @RohitBoseMDPhD @charlesryanmd @AndreaMiyahira @soulehoward1

Discussing LITESPARK-005 trial. Some patients getting good responses (22.5% PR, 3.5% CR rates) and durable PFS with #belzutifan in late line, TKI-pretreated pts. @maughanonc @_CurioScience_ #RCC

Latest updates in RCC with my good friend Dr Benjamin Maughan @maughanonc . Exciting data with belzutifan and new TKI / IO combos!#kidneycancer @_CurioScience_ @Huntsman_GU

Listening to a great talk reviewing what’s new in urothelial cancer by my good friend and colleague Dr Petros Grivas @PGrivasMDPhD #curioscience #bladdercancer

Amazing results of EV-302 trial yesterday, significant improvements in OS, PFS, ORR and CR rates. Over half of control arm pts got PD1 therapies, including 30% use of maintenance avelumab, making this an apt really world comparison.
#ESMO2023 #bladdercancer #enfortumab

Great start to the BCAN 2023 meeting!

Update on the EV-103 study. Thanks to all the of participants and their families.
ecancer.org/en/video/9738-…

First tweet!